Sarah Morrow, ceo and co-founder of Asymmetric Suzuki Reactions, making complex drug molecules that can be screened for pharmacological function
An Emerging Technology finalist outlines the innovation at the RSC's 2018 Chemistry Means Business event
Science horizons report
Emerging Technologies Competition 2018
report capture